• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N(Epsilon)-(羧甲基)赖氨酸对镰状细胞贫血患儿实验室参数的影响及其与单倍型的关系。

Effect of N(Epsilon)-(carboxymethyl)lysine on Laboratory Parameters and Its Association with Haplotype in Children with Sickle Cell Anemia.

机构信息

Laboratório de Investigação em Genética e Hematologia Translacional, Instituto Gonçalo Moniz, Salvador, BA, Brazil.

Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.

出版信息

Dis Markers. 2019 Sep 15;2019:1580485. doi: 10.1155/2019/1580485. eCollection 2019.

DOI:10.1155/2019/1580485
PMID:31636731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6766128/
Abstract

The present study aimed to investigate the association of N -carboxymethyllysine (CML) with laboratory parameters and haplotypes in pediatric sickle cell anemia (SCA) patients with or without hydroxyurea (HU) therapy. We included 55 children with SCA (SCA), where 27 were on HU treatment (SCA-HU) and 28 without HU treatment (SCA-HU). Laboratory characteristics were determined using electronic methods while CML was measured using competitive ELISA. haplotypes were determined by RFLP-PCR. Significant increases in MCV and MCH and significant decreases in leukocytes, eosinophils, basophils, atypical lymphocytes, lymphocytes, and monocytes were found in SCA-HU compared to SCA-HU. SCA-HU presented significant reduction in aspartate transaminase and lactate dehydrogenase and increase in creatinine levels compared to SCA-HU. CML levels were significantly higher in both SCA-HU and SCA-HU compared to the healthy control. In addition, a negative correlation was found between CML and alanine transaminase in SCA-HU and SCA ( < 0.01). A significant association was found between CML levels and haplotypes. The results suggest that CML has a role to play in SCA complications, independent of HU therapy.

摘要

本研究旨在探讨 N -羧甲基赖氨酸(CML)与伴有或不伴有羟基脲(HU)治疗的小儿镰状细胞贫血(SCA)患者的实验室参数和单倍型之间的关系。我们纳入了 55 名 SCA 患儿(SCA),其中 27 名接受 HU 治疗(SCA-HU),28 名未接受 HU 治疗(SCA-HU)。使用电子方法测定实验室特征,使用竞争性 ELISA 测定 CML。通过 RFLP-PCR 确定单倍型。与 SCA-HU 相比,SCA-HU 中 MCV 和 MCH 显著增加,白细胞、嗜酸性粒细胞、嗜碱性粒细胞、异型淋巴细胞、淋巴细胞和单核细胞显著减少。与 SCA-HU 相比,SCA-HU 中的天冬氨酸转氨酶和乳酸脱氢酶显著降低,肌酐水平显著升高。与健康对照组相比,SCA-HU 和 SCA-HU 中的 CML 水平均显著升高。此外,在 SCA-HU 和 SCA 中,CML 与丙氨酸转氨酶呈负相关(<0.01)。CML 水平与单倍型之间存在显著相关性。结果表明,CML 在 SCA 并发症中起作用,与 HU 治疗无关。

相似文献

1
Effect of N(Epsilon)-(carboxymethyl)lysine on Laboratory Parameters and Its Association with Haplotype in Children with Sickle Cell Anemia.N(Epsilon)-(羧甲基)赖氨酸对镰状细胞贫血患儿实验室参数的影响及其与单倍型的关系。
Dis Markers. 2019 Sep 15;2019:1580485. doi: 10.1155/2019/1580485. eCollection 2019.
2
Sickle Cell Anemia Patients in Use of Hydroxyurea: Association between Polymorphisms in Genes Encoding Metabolizing Drug Enzymes and Laboratory Parameters.羟基脲治疗镰状细胞贫血患者:编码代谢药物酶的基因多态性与实验室参数的关系。
Dis Markers. 2018 Jan 28;2018:6105691. doi: 10.1155/2018/6105691. eCollection 2018.
3
Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype.镰状细胞贫血患者的慢性炎症状态与HBB(*)S单倍型相关。
Cytokine. 2014 Feb;65(2):217-21. doi: 10.1016/j.cyto.2013.10.009. Epub 2013 Nov 27.
4
Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.α 基因、β 单倍型和 G6PD 活性对基线及羟基脲治疗下镰状细胞贫血的生物学影响。
Blood Adv. 2018 Mar 27;2(6):626-637. doi: 10.1182/bloodadvances.2017014555.
5
Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.羟基脲改变了巴西 SCA 儿童的血液学、生化和炎症生物标志物:βS 单倍型和α-地中海贫血的关联研究。
PLoS One. 2019 Jul 15;14(7):e0218040. doi: 10.1371/journal.pone.0218040. eCollection 2019.
6
Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.遗传性和生物化学标志物在镰状细胞贫血症的羟脲治疗反应中的作用。
BMC Med Genet. 2013 Oct 9;14:108. doi: 10.1186/1471-2350-14-108.
7
Is chronic use of hydroxyurea safe for patients with sickle cell anemia? An account of genotoxicity and mutagenicity.长期使用羟基脲对镰状细胞贫血患者是否安全?关于遗传毒性和致突变性的阐述。
Environ Mol Mutagen. 2019 Apr;60(3):302-304. doi: 10.1002/em.22260. Epub 2018 Dec 7.
8
Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.氧化应激、谷胱甘肽 S-转移酶多态性与羟脲治疗镰状细胞贫血的关系。
Blood Cells Mol Dis. 2011 Jun 15;47(1):23-8. doi: 10.1016/j.bcmd.2011.03.004. Epub 2011 Apr 12.
9
DNA damage in leukocytes of sickle cell anemia patients is associated with hydroxyurea therapy and with HBB*S haplotype.镰状细胞贫血病患者白细胞中的 DNA 损伤与羟基脲治疗和 HBB*S 单倍型有关。
Mutat Res. 2012 Dec 12;749(1-2):48-52. doi: 10.1016/j.mrgentox.2012.08.003. Epub 2012 Aug 16.
10
Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.羟基脲对镰状细胞贫血的影响:一项针对重度镰状细胞贫血和镰状细胞β地中海贫血儿童及青少年的临床试验。
Pediatr Hematol Oncol. 1999 May-Jun;16(3):221-32. doi: 10.1080/088800199277272.

引用本文的文献

1
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.遗传变异与镰状细胞病严重程度:系统评价和荟萃分析。
JAMA Netw Open. 2023 Oct 2;6(10):e2337484. doi: 10.1001/jamanetworkopen.2023.37484.

本文引用的文献

1
l-Glutamine for sickle cell anemia: more questions than answers.l-谷氨酰胺治疗镰状细胞贫血:问题多于答案。
Blood. 2018 Aug 16;132(7):689-693. doi: 10.1182/blood-2018-03-834440. Epub 2018 Jun 12.
2
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟基脲素)用于镰状细胞病。
Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD002202. doi: 10.1002/14651858.CD002202.pub2.
3
The past and present of serum aminotransferases and the future of liver injury biomarkers.血清转氨酶的过去与现在以及肝损伤生物标志物的未来
EXCLI J. 2016 Dec 15;15:817-828. doi: 10.17179/excli2016-800. eCollection 2016.
4
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies.镰状细胞病中的胎儿血红蛋白:从遗传流行病学到新的治疗策略。
Lancet. 2016 Jun 18;387(10037):2554-64. doi: 10.1016/S0140-6736(15)01341-0.
5
The Role of Oxidative Stress and Antioxidants in Liver Diseases.氧化应激与抗氧化剂在肝脏疾病中的作用
Int J Mol Sci. 2015 Nov 2;16(11):26087-124. doi: 10.3390/ijms161125942.
6
Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.羟基脲:镰状细胞贫血患者的临床和血液学效应
Glob J Health Sci. 2015 Aug 19;8(3):252-6. doi: 10.5539/gjhs.v8n3p252.
7
Glomerular filtration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC.镰状细胞病患儿的肾小球滤过率发生改变:Hb SS与Hb SC的比较。
Rev Bras Hematol Hemoter. 2013;35(5):349-51. doi: 10.5581/1516-8484.20130107.
8
Emerging science of hydroxyurea therapy for pediatric sickle cell disease.儿童镰状细胞病羟基脲治疗的新兴科学。
Pediatr Res. 2014 Jan;75(1-2):196-204. doi: 10.1038/pr.2013.227. Epub 2013 Nov 19.
9
Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil.羟基脲疗法对镰状细胞病患者的临床和血液学影响:巴西的单中心经验
Sao Paulo Med J. 2013;131(4):238-43. doi: 10.1590/1516-3180.2013.1314467.
10
Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros.在蒙特斯克拉罗斯地区血液中心服用羟基脲的镰状细胞病患者。
Rev Bras Hematol Hemoter. 2011;33(2):105-9. doi: 10.5581/1516-8484.20110029.